151 related articles for article (PubMed ID: 10465505)
1. Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects.
Kong MF; Chapman I; Goble E; Wishart J; Wittert G; Morris H; Horowitz M
Peptides; 1999; 20(5):545-51. PubMed ID: 10465505
[TBL] [Abstract][Full Text] [Related]
2. Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans.
Rayner CK; Park HS; Wishart JM; Kong M; Doran SM; Horowitz M
Am J Physiol Regul Integr Comp Physiol; 2000 Feb; 278(2):R360-6. PubMed ID: 10666136
[TBL] [Abstract][Full Text] [Related]
3. Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages.
Bowen J; Noakes M; Clifton PM
Int J Obes (Lond); 2007 Nov; 31(11):1696-703. PubMed ID: 17593904
[TBL] [Abstract][Full Text] [Related]
4. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
Lavin JH; Wittert GA; Andrews J; Yeap B; Wishart JM; Morris HA; Morley JE; Horowitz M; Read NW
Am J Clin Nutr; 1998 Sep; 68(3):591-8. PubMed ID: 9734735
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
Toft-Nielsen MB; Madsbad S; Holst JJ
Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects.
Adam TC; Westerterp-Plantenga MS
Br J Nutr; 2005 Jun; 93(6):845-51. PubMed ID: 16022753
[TBL] [Abstract][Full Text] [Related]
7. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man.
Long SJ; Sutton JA; Amaee WB; Giouvanoudi A; Spyrou NM; Rogers PJ; Morgan LM
Br J Nutr; 1999 Apr; 81(4):273-9. PubMed ID: 10999014
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint A; Raben A; Astrup A; Holst JJ
J Clin Invest; 1998 Feb; 101(3):515-20. PubMed ID: 9449682
[TBL] [Abstract][Full Text] [Related]
9. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.
Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI
Eur J Clin Nutr; 2003 Feb; 57(2):293-8. PubMed ID: 12571662
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucose supplementation on gastric emptying, blood glucose homeostasis, and appetite in the elderly.
Beckoff K; MacIntosh CG; Chapman IM; Wishart JM; Morris HA; Horowitz M; Jones KL
Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R570-6. PubMed ID: 11208589
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.
Näslund E; Gutniak M; Skogar S; Rössner S; Hellström PM
Am J Clin Nutr; 1998 Sep; 68(3):525-30. PubMed ID: 9734726
[TBL] [Abstract][Full Text] [Related]
12. Glycemic, hormone, and appetite responses to monosaccharide ingestion in patients with type 2 diabetes.
Vozzo R; Baker B; Wittert GA; Wishart JM; Morris H; Horowitz M; Chapman I
Metabolism; 2002 Aug; 51(8):949-57. PubMed ID: 12145765
[TBL] [Abstract][Full Text] [Related]
13. Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.
Kuhre RE; Gribble FM; Hartmann B; Reimann F; Windeløv JA; Rehfeld JF; Holst JJ
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G622-30. PubMed ID: 24525020
[TBL] [Abstract][Full Text] [Related]
14. Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides.
Steinert RE; Frey F; Töpfer A; Drewe J; Beglinger C
Br J Nutr; 2011 May; 105(9):1320-8. PubMed ID: 21255472
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
Gutzwiller JP; Drewe J; Göke B; Schmidt H; Rohrer B; Lareida J; Beglinger C
Am J Physiol; 1999 May; 276(5):R1541-4. PubMed ID: 10233049
[TBL] [Abstract][Full Text] [Related]
16. 1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice.
Ahrén B; Holst JJ; Yu S
Eur J Pharmacol; 2000 May; 397(1):219-25. PubMed ID: 10844116
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH
Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
[TBL] [Abstract][Full Text] [Related]
19. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Meier JJ; Kemmeries G; Holst JJ; Nauck MA
Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1: a potent regulator of food intake in humans.
Gutzwiller JP; Göke B; Drewe J; Hildebrand P; Ketterer S; Handschin D; Winterhalder R; Conen D; Beglinger C
Gut; 1999 Jan; 44(1):81-6. PubMed ID: 9862830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
